Enavate Sciences GP, LLC Q4 2025 Filing

Filed February 17, 2026

Portfolio Value

$506.8M

Holdings

7

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (7 positions)

#StockSharesValue% PortfolioType
1
ZBIOZENAS BIOPHARMA INC
3,919,159$142.3M28.08%
2
IMNMIMMUNOME INC
4,768,583$102.4M20.21%
3
SIONSIONNA THERAPEUTICS INC
2,478,030$101.9M20.12%
4
UPBUPSTREAM BIO INC
2,459,703$66.8M13.18%
5
CMPXCOMPASS THERAPEUTICS INC
7,788,150$41.8M8.25%
6
BBOTBRIDGEBIO ONCOLOGY THERAPEUT
2,626,946$32.9M6.49%
7
CAMPCAMP4 THERAPEUTICS CORP
3,035,825$18.6M3.67%